Vyuhaa Med Data - About the company
Vyuhaa Med Data is a seed company based in Hyderabad (India), founded in 2022 by Dhritiman Mallick. It operates as an AI based digital pathology solutions for cervical cancer screening and diagnosis. Vyuhaa Med Data has raised $159K in funding, with a current valuation of ₹*****. The company has 90 active competitors, including 36 funded and 6 that have exited. Its top competitors include companies like Lunit, Ibex and Valar Labs.
Company Details
AI based digital pathology solutions for cervical cancer screening and diagnosis. It utilizes NVIDIA hardware combined with google cloud to provide an accurate cancer detection. It provides solution called CerviAI, which leverages data driven innovation to enhance the accuracy of early cervical cancer detection. The system employs a digitizer capable of without loss of image quality, offering detailed visuals for accurate diagnosis.
- Website
- vyuhaadata.com
- Email ID
- *****@vyuhaadata.com
- Phone Number
- +91 **********
- Registered Address
- 4/608 G1 VOC Street Perungudi, OMR Chennai, Neelankarai, Kanchipuram, Chennai City Corporation, Tamil Nadu, India, 600041
Key Metrics
Founded Year
2022
Location
Hyderabad, India
Stage
Seed
Total Funding
$159K in 1 round
Latest Funding Round
Post Money Valuation
₹***** as on Jan 20, 2026
Ranked
30th among 90 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
17 as on Sep 30, 2026
Legal entities associated with Vyuhaa Med Data
Vyuhaa Med Data is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
VYUHAA MED DATA PRIVATE LIMITED CIN: U72900TN2022PTC151148 , India, Active | Apr 06, 2022 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download Vyuhaa Med Data's company profile
Vyuhaa Med Data's funding and investors
Vyuhaa Med Data has raised a total funding of $159K over 1 round. Its latest funding round was a Seed round on Jan 10, 2026 for ₹*****. 1 investor participated in its latest round. Vyuhaa Med Data has 2 institutional investors.
Here is the list of recent funding rounds of Vyuhaa Med Data:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 10, 2026 | 1569065 | Seed | 8351295 | 1989093 | 9403596 | 9126828 |
View details of Vyuhaa Med Data's funding rounds and investors
Vyuhaa Med Data's founders and board of directors
Founder? Claim ProfileThe founders of Vyuhaa Med Data is Dhritiman Mallick. Dhritiman Mallick is the CEO of Vyuhaa Med Data.
Here are the details of Vyuhaa Med Data's key team members:
- Dhritiman Mallick: Co-Founder & CEO of Vyuhaa Med Data. Contact Info: 1 email address
View details of Vyuhaa Med Data's Founder profiles and Board Members
Vyuhaa Med Data's employee count trend
Vyuhaa Med Data has 17 employees as of Sep 26. Here is Vyuhaa Med Data's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vyuhaa Med Data's Competitors and alternates
Top competitors of Vyuhaa Med Data include Lunit, Ibex and Valar Labs. Here is the list of Top 10 competitors of Vyuhaa Med Data, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Lunit 2013, Seoul (South Korea), Public | Developer of medical software for cancer screening and oncology diagnostics | $135M | 67/100 | |
2nd | Provider of AI-powered diagnostic solutions for pathology | $114M | 64/100 | ||
3rd | Valar Labs 2021, Palo Alto (United States), Series A | Developer of AI diagnostics for predicting cancer treatment response likelihood | $26.1M | 62/100 | |
4th | Proscia 2014, Philadelphia (United States), Acquired | Provider of an AI and cloud-based digital pathology solution for cancer diagnosis | $129M | 61/100 | |
5th | Aignostics 2018, Berlin (Germany), Series B | Developer of artificial intelligence software for biomedical image analysis applications | $53.9M | 61/100 | |
6th | Provider of AI-based pathological analysis platform | $18.3M | 59/100 | ||
7th | Onc.ai 2020, San Carlos (United States), Series A | AI-based cancer treatment and diagnosis platform for healthcare providers | $31M | 57/100 | |
8th | Enspectra Health 2014, Mountain View (United States), Series A | Developer of medical devices for tissue imagining and cancer detection | $15.5M | 55/100 | |
9th | PAIGE 2018, New York City (United States), Acquired | Developer of AI applications and foundation models for cancer diagnostics | $241M | 55/100 | |
10th | Provider of AI-based software for detection of cancer | $15.7M | 54/100 | ||
30th | Vyuhaa Med Data 2022, Hyderabad (India), Seed | AI based digital pathology solutions for cervical cancer screening and diagnosis | $159K | 36/100 |
Looking for more details on Vyuhaa Med Data's competitors? Click here to see the top ones
Vyuhaa Med Data's Investments and acquisitions
Vyuhaa Med Data has made no investments or acquisitions yet.
Reports related to Vyuhaa Med Data
Here is the latest report on Vyuhaa Med Data's sector:
Are you a Founder ?
FAQs about Vyuhaa Med Data
Explore our recently published companies
- Vruddhi Inc - Mumbai based, 2005 founded, Unfunded company
- Broadsidemarketplace - Unfunded company
- rane.fr - France based, 2002 founded, Unfunded company